Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ANI Pharma Inc (NQ: ANIP )

28.96 -1.22 (-4.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 144,623
Open 30.27
Bid (Size) 20.00 (1)
Ask (Size) 47.95 (4)
Prev. Close 30.18
Today's Range 28.73 - 30.88
52wk Range 22.31 - 60.23
Shares Outstanding 24,422,240
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals's Return On Capital Employed Overview
According to data from Benzinga Pro, during Q1, ANI Pharmaceuticals's (NASDAQ:ANIP) reported sales totaled $64.48 million. Despite a 16.6% increase in earnings, the company posted a loss of $20.13... 
Via Benzinga

Performance

YTD
-38.58%
-38.58%
1 Month
-4.26%
-4.26%
3 Month
+0.31%
+0.31%
6 Month
-40.34%
-40.34%
1 Year
-12.32%
-12.32%

More News

Read More
ANI Pharmaceuticals Announces Consolidation of Manufacturing Network, Capturing Operational Synergies Post Novitium Acquisition
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces the FDA Approval and Imminent Launch of Fludrocortisone Acetate Tablets USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals: Q1 Earnings Insights
Via Benzinga
ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Q1 2022 Earnings Conference Call On May 10, 2022 At 08:30 AM ET
Via Benzinga
ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets
From ANI Pharmaceuticals, Inc.
Via Business Wire
Insider Weekends: Return Of The Meme Stocks - GameStop (GME) And AMC Entertainment (AMC)
Via Benzinga
ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals's Return On Capital Employed Insights
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Rises Over 200 Points; ANI Pharmaceuticals Shares Slide
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Upbeat Inflation Data, Falling Oil Prices Prop Up Dow
Via Talk Markets
Mid-Day Market Update: Dow Surges Over 300 Points; Crude Oil Tumbles 8%
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; US Producer Prices Increase 0.8% In February
Via Benzinga
ANI Pharma Posts Mixed Bag Q4 Earnings, FY22 Sales Outlook Trails Street Consensus
Via Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
Via Benzinga
ANI Pharmaceuticals: Q4 Earnings Insights
Via Benzinga
ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth
From ANI Pharmaceuticals, Inc.
Via Business Wire
Earnings Scheduled For March 15, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.